Here comes the stock deluge
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel expresses bearish sentiments due to potential dilution from massive equity issuance by tech giants like Alphabet, SpaceX, and Anthropic/OpenAI for AI infrastructure. They argue that this could lead to a liquidity crunch, compress multiples, and potentially destroy shareholder value if AI capex ROI disappoints.
Risk: Permanent shareholder value destruction due to dilution and multiple compression if AI capex ROI disappoints.
Opportunity: Accelerated AI capacity growth if deployment proves efficient and ROIC exceeds cost of capital.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Alphabet, one of the most cash-rich companies in American history, has decided to sell new shares to help pay for its AI data centers .
Why it matters: It's an object lesson in how the AI boom may be disrupting trends — such as the steady "shrinkage" of the stock market due to share buybacks — that have been sources of market stability for years.
State of play: Alphabet's plan to sell $80 billion in shares — announced after Monday's close — caught the market by surprise, sending the stock down by roughly 4% as investors digested the dilution the sale represented.
Context: It was the latest in a flurry of plans from tech giants to raise cash through stock sales to pay for the AI boom.
- Top AI lab Anthropic — recently valued at nearly $1 trillion by private investors — announced Monday that it had confidentially filed plans with the SEC for its public offering. (The details of the offering have not been finalized, but it is expected to be one of the largest in history.)
- OpenAI is also reportedly close to a confidential filing in advance of its own public offering.
- And last week, Elon Musk's SpaceX publicly filed plans to raise an expected $75 billion in a share sale, which, if successful, would eclipse Saudi Aramco's IPO as the largest-ever initial offering. (SpaceX owns Musk's AI lab Grok.)
By the numbers: The scale of those offerings has supercharged expectations for the market in new stocks this year.
- Goldman Sachs U.S. equity analysts now expect large companies to raise a record $225 billion in IPOs this year, almost six times as much as last year.
The intrigue: The IPO surge has prompted a flurry of questions about where the money to buy the stock will come from. Wall Street doesn't seem worried.
What they're saying: "Public equity markets remain capable of absorbing a materially larger AI financing cycle than current issuance levels imply," wrote Morgan Stanley analysts in a note last week. "In the U.S. specifically, a return to historical average and peak levels would represent $0.7 trillion and $1.1 trillion, respectively, both far greater than ~$500 billion of US equity capital market issuance in 2025."
Yes, but: Even so, these sales of stock may represent a milestone for the structure of the U.S. stock market.
- "Since the early 2000s, a confluence of factors systematically reduced available public equity year after year," wrote Savita Subramanian, head of U.S. equity and quantitative strategy at Bank of America Securities. "More buybacks, longer private incubations, more take-privates, low rates, ample liquidity, etc. Today, an issuance deluge may be imminent."
AI is moving fast. Axios AI+ keeps you ahead. Sign up free at Axios.com.
Four leading AI models discuss this article
"The 'deluge' signals not market strength but a structural shift from debt-funded buybacks to equity dilution, removing a 20-year tailwind just as valuations depend on it most."
The article frames this as a structural pivot—buybacks shrinking the float for 20 years, now reversed. But the framing obscures a critical distinction: Alphabet, Anthropic, OpenAI, and SpaceX aren't raising capital because equity markets are 'absorbing' demand; they're raising because debt markets won't fund AI capex at the scale or speed needed. That's not market strength—it's a forced substitution. Morgan Stanley's $700B–$1.1T absorption capacity sounds reassuring until you ask: at what valuation? If $225B in IPOs lands in a market where AI ROI remains unproven and rates stay elevated, you get dilution without the offsetting buyback bid that propped equities for two decades.
If these companies genuinely believe in their AI returns, equity issuance is rational capital allocation—cheaper than debt given their risk profile. And a $225B IPO surge is still small relative to $40+ trillion U.S. equity market cap; historical precedent suggests absorption is plausible.
"Equity supply from AI capex is likely to exceed absorption capacity in 2025, pressuring multiples even if earnings rise."
Alphabet's $80B equity raise for AI infrastructure, alongside SpaceX's $75B filing and pending Anthropic/OpenAI IPOs, marks a reversal of two decades of net equity shrinkage via buybacks. Goldman Sachs' $225B IPO forecast implies supply could reach 0.7-1.1T annually per Morgan Stanley, exceeding 2025 issuance. This risks diluting returns for existing shareholders in GOOGL and peers if AI ROI falls short of the implied capex intensity. The market's ability to absorb depends on sustained inflows, yet private-to-public rotation at trillion-dollar valuations introduces timing risk not fully priced in.
Record issuance could be absorbed without pressure if AI-driven EPS growth materializes faster than dilution, as historical tech cycles show equity raises often precede multiple expansion rather than compression.
"The transition from a net-buyback market to a net-issuance market will compress equity risk premiums and end the era of multiple expansion for mega-cap tech."
The narrative that Alphabet (GOOGL) is selling $80 billion in stock to fund AI is a critical inflection point. For a decade, the 'buyback machine' suppressed supply, artificially propping up EPS growth and P/E multiples. Now, we are shifting from a net-supply-contraction environment to a net-supply-expansion phase. While Morgan Stanley argues the market can absorb this, they ignore the 'crowding out' effect: if institutional liquidity is diverted into massive IPOs like SpaceX or Anthropic, the valuation premium on existing mega-cap tech will inevitably compress. We are moving from a scarcity-driven bull market to one where capital efficiency is penalized by the sheer cost of AI infrastructure.
The deluge of supply could actually be a sign of market health, signaling that the 'AI winter' is over and capital is finally being deployed toward productive, high-growth infrastructure rather than yield-starved financial engineering.
"Massive equity issuance for AI bets could normalize dilution as a financing tool, pressuring stock multiples and crowding out buybacks, risking a protracted re-rating of tech equities."
Alphabet's plan to raise $80B via new shares to fund AI data centers signals a shift from buybacks toward equity issuance as the growth-financing tool. Dilution is real and could weigh on near-term EPS, but proceeds could accelerate AI capacity with ROIC above cost of capital if deployment proves efficient. The article omits pricing details, timing, exact use-of-proceeds, and who will buy the shares, making it hard to judge true dilution impact. A wave of AI-related offerings could saturate demand and compress multiples if growth expectations wobble, while energy costs and regulatory risks for data centers remain meaningful headwinds.
Dilution can be value-accretive if the proceeds are deployed at ROIC well above Alphabet's cost of capital and the issue is priced to demand; if AI monetization accelerates, the stock could rebound despite the equity raise.
"Timing risk at peak valuations compounds dilution risk if AI ROI misses—this isn't priced into current GOOGL multiples."
ChatGPT flags the article's omission of pricing and timing—valid. But nobody's addressed the elephant: if Alphabet prices this $80B raise at current multiples (say, 25x forward P/E), they're issuing ~3.2B shares at peak valuations. That's a 2.4% dilution in one tranche. If AI capex ROI disappoints and multiples compress to 18x, that dilution becomes permanent shareholder value destruction. The 'value-accretive if ROIC exceeds cost of capital' argument assumes execution certainty we don't have.
"The $225B IPO wave could force Alphabet's raise to price at a discount, amplifying dilution beyond the 2.4% Claude calculated."
Claude's dilution math assumes a static multiple, but ignores how the $225B IPO pipeline Gemini flagged could force Alphabet to issue at a discount to clear demand. If SpaceX and Anthropic listings compete for the same institutional capital in 2025, the effective shares issued for that $80B might exceed 3.2B, locking in higher dilution regardless of AI returns. This sequencing risk remains unpriced.
"The shift from debt to equity financing for AI capex signals a broader liquidity crunch that will force a sector-wide repricing of the tech risk premium."
Grok, your focus on sequencing risk is vital, but you're missing the liquidity drain from the bond market. If Alphabet and others pivot to equity because debt markets are saturated or too expensive, we aren't just seeing a rotation; we are seeing a liquidity crunch. The real danger isn't just dilution—it's the potential for a 'valuation vacuum' where the sheer volume of supply forces a total repricing of the tech sector's risk premium, regardless of individual AI execution.
"Use-of-proceeds quality and pricing discipline determine whether dilution becomes a drag or a catalyst, not supply volume alone."
Responding to Gemini: The 'valuation vacuum' risk is real, but treating all new AI-related supply as a one-way drag ignores demand discipline from strategic buyers and AI-specific equity mandates. If ROIC on AI capex proves high, the market may prize growth over supply, keeping multiples intact or even expanding. The key is use-of-proceeds quality and pricing discipline; otherwise dilution plus a weaker terminal multiple becomes a real risk.
The panel expresses bearish sentiments due to potential dilution from massive equity issuance by tech giants like Alphabet, SpaceX, and Anthropic/OpenAI for AI infrastructure. They argue that this could lead to a liquidity crunch, compress multiples, and potentially destroy shareholder value if AI capex ROI disappoints.
Accelerated AI capacity growth if deployment proves efficient and ROIC exceeds cost of capital.
Permanent shareholder value destruction due to dilution and multiple compression if AI capex ROI disappoints.